Invention Grant
- Patent Title: Recombinant expression of Chlamydia MOMP antigen
-
Application No.: US15527789Application Date: 2015-11-16
-
Publication No.: US10675339B2Publication Date: 2020-06-09
- Inventor: Lan Zhang , Zhiyun Wen , Craig T. Przysiecki , Puneet Khandelwal
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Letitia Walker; Laura M. Ginkel
- International Application: PCT/US2015/060780 WO 20151116
- International Announcement: WO2016/081327 WO 20160526
- Main IPC: C12P21/06
- IPC: C12P21/06 ; C12P21/04 ; C12N15/64 ; A61K39/02 ; C07K14/295 ; A61P31/04 ; C12N15/70 ; A61K39/00

Abstract:
The present invention relates to methods for the recombinant expression of Chlamydia major outer membrane protein (MOMP) comprising transforming a population of E. coli host cells with an expression vector comprising a nucleic acid molecule that encodes Chlamydia MOMP and encodes a leader sequence for targeting the MOMP to the outer membrane of the cell, wherein the nucleic acid molecule is operatively linked to a promoter. The method of the invention allows expression of MOMP in the outer membrane of the cell, which leads to protein folding that is more like native MOMP relative to a MOMP protein that is expressed intracellularly. Also provided by the invention are uses of the recombinant MOMP in pharmaceutical compositions and methods for the treatment and/or prophylaxis of Chlamydia infection and/or the effects thereof.
Public/Granted literature
- US20190046626A1 RECOMBINANT EXPRESSION OF CHLAMYDIA MOMP ANTIGEN Public/Granted day:2019-02-14
Information query